|
It was reported that the bd luer-lok had a syringe needle connectivity issue.The following information was provided by the initial reporter: "when using the 1ml tuberculin slip tip syringe with bd eclipse needle separation occurs at the junction point causing the unsafe situation as the needle is exposed before administering medication and there is a chance of staff accidentally poking themselves.Another incident occured where the syringe dislodged from the needle while withdrawing the injection, leaving the needle in the patients body.The needle had to be then removed separately, creating unsafe situation." impact of incident: outcome was prolonged agitation for the patient as the medication administration was delayed.Ahs mdip reference number (id): (b)(4).Date of incident (yyyy-mm-dd): (b)(6) 2023.Site name/location: (b)(6) medical centre.Level of harm: no apparent harm ¿ close call.Ahs optional report to cmdsnet (health canada): incident details: when using the 1ml tuberculin slip tip syringe with bd eclipse needle separation occurs at the junction point causing the unsafe situation as the needle is exposed before administering medication and there is a chance of staff accidentally poking themselves.Another incident occured where the syringe dislodged from the needle while withdrawing the injection, leaving the needle in the patients body.The needle had to be then removed separately, creating unsafe situation.Impact of incident: outcome was prolonged agitation for the patient as the medication administration was delayed.Who was affected? patient.Device name/description: syringe slip tip tuberculin sterile latex free disposable 1ml manufacturer: becton dickinson canada inc.Manufacturer code/model: 309659.Serial or lot number: (b)(6).Device expiry date (yyyy-mm-dd): unknown.Supplier: (b)(4).Supplier catalogue number: 308-309659.Was the device retained? no.Additional information received on 01/05/2024: 1.Any sample or photo available for investigation? if yes, are you able to provide the address of the facility for us to ship the return label? no.2.Please confirm the date of event of both the incident.1st incident (b)(6) 2023 / 2nd incident around the same time exact date unknown.3.Did the event directly, or indirectly involve a patient or user? before use in nov 16 incident, during use in the other incident.4.Did the event involve an urgent/life threatening medical situation? no ¿ close call.5.Describe any patient harm, injury, complication or negative outcome that occurred as a result of the event.Please include treatment/intervention provided and the outcome.Outcome was prolonged agitation for the patient as the medication administration was delayed.
|
|
(b)(4) - follow up mdr for device evaluation.Since no samples displaying the condition reported are available for examination, we were unable to fully investigate this incident.No root cause can be determined as no samples were received.Furthermore, a device history record review showed no rejected inspections or quality issues during the production of the provided lot number that could have contributed to the reported defect.It is recommended to hand tighten the needle onto the syringe prior to use.We would be very interested in examining product that does not meet your expectations and our quality standards.Should you again experience any problems with our product we would appreciate the opportunity to conduct a thorough analysis.Examination of the product involved may provide clarification as to the cause for the reported failure.We appreciate you taking the time to bring this observation to our attention.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored monthly.Our business team regularly reviews the collected data for identification of emerging trends.
|